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Abstract: Seaweeds are gaining a considerable amount of attention for their antioxidant and
antibacterial properties. Caulerpa racemosa and Caulerpa lentillifera, also known as ‘sea grapes’,
are green seaweeds commonly found in different parts of the world, but the antioxidant and
antibacterial potentials of Malaysian C. racemosa and C. lentillifera have not been thoroughly explored.
In this study, crude extracts of the seaweeds were prepared using chloroform, methanol, and water.
Total phenolic content (TPC) and total flavonoid content (TFC) were measured, followed by in vitro
antioxidant activity determination using 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging
assay. Antibacterial activities of these extracts were tested against Methicillin-resistant Staphylococcus
aureus (MRSA) and neuropathogenic Escherichia coli K1. Liquid chromatography–mass spectrometry
(LCMS) analysis was then used to determine the possible compounds present in the extract with
the most potent antioxidant and antibacterial activity. Results showed that C. racemosa chloroform
extract had the highest TPC (13.41 ± 0.86 mg GAE/g), antioxidant effect (EC50 at 0.65 ± 0.03 mg/mL),
and the strongest antibacterial effect (97.7 ± 0.30%) against MRSA. LCMS analysis proposed that
the chloroform extracts of C. racemosa are mainly polyunsaturated and monounsaturated fatty acids,
terpenes, and alkaloids. In conclusion, C. racemosa can be a great source of novel antioxidant and
antibacterial agents, but isolation and purification of the bioactive compounds are needed to study
their mechanism of action.
Keywords: antibacterial; antioxidant; macroalgae; Caulerpa racemosa; Caulerpa lentillifera; bioactive
compounds; liquid chromatography–mass spectrometry
1. Introduction
Marine organisms such as seaweeds are a rich source of natural bioactive compounds. Studies
have shown that seaweeds have various bioactive constituents such as proteins, polysaccharides,
and secondary metabolites [1–4]. The presence of the bioactive compounds has been found to contribute
to anti-inflammatory, antioxidant, and antimicrobial properties [5–8]. One of the bioactive compounds
isolated from Chondrus cripus, iota-carrageenan, is currently used as an active ingredient in nasal spray
products as part of the treatment for the common cold in adults. This sulphated polysaccharide binds
to respiratory viruses, limiting the viral attachment to host cells [9]. Alginate, a polysaccharide isolated
from brown seaweed (Phaeophycae), is formulated as an alginate-antacid to reduce postprandial acid
reflux in patients with gastroesophageal reflux disease. The alginate-based formulation forms a layer
on top of the gastric content, neutralizing the acid film [10]. In both cases, these bioactive compounds
have demonstrated to be effective and beneficial, highlighting the invaluable pharmaceutical potential
that seaweeds can offer.
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In recent years, the consumption of antioxidant rich foods has become a trend in view of their
protective effects against reactive oxygen species (ROS) and the associated health conditions [11–13].
ROS are known to induce oxidative injury in human cells, leading to the onset of various chronic
diseases, including Alzheimer’s disease, cancers, and aging [14–18]. Studies have shown that seaweeds
possess bioactive compounds with strong antioxidant capacity to protect seaweeds against ROS [19–21].
The antioxidant compounds from seaweeds may belong to the main classes of phytochemicals known
as phenolics and flavonoids (a derivative of phenolics), due to the presence of hydroxyl groups, which
act as hydrogen-donors to stabilize the free radicals and to terminate the generation of new free
radicals [22]. There are studies showing a positive correlation between total phenolic content and total
flavonoid content in seaweed with antioxidant activity [23–27]. However, more in-depth studies are
required in this area to identify the antioxidant compounds.
Additionally, seawater is teeming with microorganisms. A study found a significant degree of
microbial diversity from ocean water samples, with 247 bacterial strains identified [28]. Interestingly,
seaweeds can grow abundantly in seawater, indicating that they may have a plethora of bioactive
compounds that allow their co-existence with microorganisms [29,30]. In fact, various studies have
shown that seaweeds are a potent source of antibacterial agents [1,31]. The antibacterial potential
has become an inspiration to researchers to develop effective antibacterial drugs to combat infectious
diseases, which are claiming lives at an alarming rate. Each year, 50,000 deaths in the U.S. and Europe
are attributed to antibiotic-resistant bacteria (ARB) diseases and if the problem with ARB remains
unmonitored, it is estimated that they may lead to 10 million cases of death annually by 2050 [32].
The existence of ARB limits the types of antibiotics that can be prescribed to the patients and, thus,
increases the mortality rate significantly. This scenario shows that bacteria are evolving and adapting
quickly to newly-introduced antibiotics, while the development of novel antibiotics is still struggling
to catch up.
In Malaysia, there are more than 386 taxa of marine seaweeds found, and many of these Malaysian
seaweeds have been demonstrated to possess promising antibacterial, antioxidant, and antiviral
properties [33–37]. Caulerpa racemosa and Caulerpa lentillifera, also known as ‘sea grapes’, are green
seaweeds eaten raw as salad and cultivated in different parts of the world, particularly in the
Indo–Pacific region [38,39]. There are several preliminary studies that have reported on the antioxidant
and antibacterial effects of Malaysian green seaweeds C. racemosa and C. lentillifera [21,35,36,38,40,41],
as well as the antibacterial effects of C. racemosa and C. lentillifera from India and Egypt [42–45].
The bioactive compounds responsible for the antioxidant and antibacterial effects in C. racemosa and
C. lentillifera, however, are not known. This situation suggests that there is still a large gap to fill
to discover the possible nature and identity of the bioactive compounds of interest from Malaysian
C. racemosa and C. lentillifera.
Therefore, in the present study, we aimed to decipher the antioxidant and antibacterial properties
of Malaysian C. racemosa and C. lentillifera by (1) performing phytochemical screenings to evaluate
the total phenolic and flavonoid contents, (2) determining the antioxidant activity, (3) investigating
the antibacterial activity, (4) partially characterizing the nature of the antibacterial effect, and (5)
identifying the possible compounds present in the extract with the most promising antioxidant
and antibacterial effects by liquid chromatography–mass spectrometry (LCMS) analysis. The key
findings of this study will provide important insight into the antioxidant and antibacterial potentials
of Malaysian green seaweeds C. racemosa and C. lentillifera to be used as novel sources of antioxidant
and antibacterial compounds.
2. Results
2.1. Yield Percentage of Seaweed Extracts
Table 1 shows the amount of chloroform, methanol, and water extracts obtained from C. racemosa
and C. lentillifera and their respective yield percentages. The yield percentage of the water extract of
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C. lentillifera is significantly higher (p < 0.05) than that of all other extracts obtained, including extracts
from C. racemosa. On the other hand, the lowest yield percentages are from the chloroform extracts of
both C. racemosa and C. lentillifera.
Table 1. Yield percentages of seaweed extracts from each seaweed species.
Seaweed Species Extract Mass of Extract Obtained (g) Yield (%)
Chloroform 0.053 ± 0.001 5.212 ± 0.106 a
C. racemosa Methanol 0.126 ± 0.004 12.554 ± 0.434 b
Water 0.133 ± 0.002 12.920 ± 0.289 b
Chloroform 0.052 ± 0.005 5.081 ± 0.462 a
C. lentillifera Methanol 0.138 ± 0.015 13.450 ± 1.429 b
Water 0.319 ± 0.020 30.884 ± 2.006 c
Data show the mass of seaweed extracts obtained and their respective yields. Extracts were prepared by incubating
1 g of seaweed powder with the appropriate solvent (50 mL) for 2 h. The filtrates collected were subjected to rotary
evaporation and then further concentrated using vacuum concentrator. The extracts obtained were stored at −20 ◦C
prior to use. Data are expressed as mean ± SE of three separate independent extractions. Means with different
alphabet are significantly different at p < 0.05 (Tukey).
2.2. Determination of Total Phenolic Content (TPC) and Total Flavonoid Content (TFC)
The TPC in C. racemosa and C. lentillifera extracts was quantified by using the Folin Ciocalteu
method. Table 2 shows a similar trend in the TPC of C. racemosa and C. lentillifera extracts, decreasing
in the following order: Chloroform > methanol > water. Notably, the TPC of the chloroform extract
of C. racemosa (13.41 ± 0.86 mg GAE/g) is significantly higher (p < 0.05) compared to other extracts,
including those in C. lentillifera. In the case of C. lentillifera, the TPC in the chloroform extract (5.47 ± 0.75
mg GAE/g) is higher than both the water extract and the methanol extract, but it is only significantly
higher (p < 0.05) compared to the water extract. Taken together, the TPC results suggest that both
C. racemosa and C. lentillifera contain mostly of less polar phenolics.
Table 2. The total phenolic content (TPC) and total flavonoid content (TFC) in C. racemosa and C.
lentillifera crude extracts.
Seaweed Species Extract TPC (mg GAE/g) TFC (mg QE/g)
Chloroform 13.41 ± 0.86 a 5.46 ± 0.41 a,c,e
C. racemosa Methanol 10.33 ± 0.02 b 24.52 ± 2.17 b
Water 1.74 ± 0.09 c 2.50 ± 0.10 a,c
Chloroform 5.47 ± 0.75 d 0.28 ± 0.03 d
C. lentillifera Methanol 4.52 ± 0.42 d 4.93 ± 0.27 a,e
Water 2.04 ± 0.36 c 1.17 ± 0.03 f
Data are expressed as mean ± SE of triplicates in three separate independent experiments. TPC values are expressed
as milligram gallic acid equivalent per gram (mg GAE/g). TFC values are expressed as milligram Quercetin
equivalent per gram (mg QE/g). Means with different alphabet are significantly different at p < 0.05 (Tukey for TPC;
Games–Howell for TFC).
The TFC results show that methanol extracts of both C. racemosa and C. lentillifera contain a higher
amount of flavonoid compared to chloroform and water extracts. The TFC of the methanolic extract
of C. racemosa (24.52 ± 2.17 mg QE/g) is significantly higher (p < 0.05) than the TFC of other extracts,
including those in C. lentillifera. Meanwhile, in the case of C. lentillifera, the TFC of the methanolic
extract (4.93 ± 0.27 mg QE/g) is significantly higher (p < 0.05) than that of the chloroform extract and
the water extract by approximately 17-fold and 4-fold, respectively.
2.3. Determination of DPPH Radical Scavenging Activity
Results of in vitro antioxidant activity of C. racemosa and C. lentillifera are tabulated in Table 3.
A lower EC50 value indicates a higher antioxidant activity and vice versa. In both species of seaweeds,
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the trend in terms of their respective antioxidant activity decreases in the following order: Chloroform
> methanol > water. It is observed that the chloroform extract of C. racemosa shows the highest
significant (p < 0.05) antioxidant activity (EC50 at 0.65 ± 0.03 mg/mL) compared with other extracts of
this species. However, its antioxidant activity is significantly lower (p < 0.05) than that of ascorbic acid
(EC50 at 0.01 ± 0.0005 mg/mL). Similarly, by comparing the antioxidant activity of C. lentillifera alone,
its chloroform extract has significantly higher (p < 0.05) antioxidant activity (EC50 at 2.20 ± 0.10 mg/mL)
compared to the other extracts within this species. Interestingly, by comparing across the two seaweed
species, the chloroform extract of C. racemosa has the significantly highest (p < 0.05) antioxidant activity
(EC50 at 0.65 ± 0.03 mg/mL) compared to all other extracts tested, while the water extract of C. lentillifera
has the significantly lowest (p < 0.05) antioxidant activity (EC50 at 81.55 ± 4.22 mg/mL).
Table 3. The DPPH radical scavenging activity of C. racemosa and C. lentillifera crude extracts.
Standard and Seaweed Species Control and Extract EC50 (mg/mL)
Standard Ascorbic Acid 0.01 ± 0.0005 a
Chloroform 0.65 ± 0.03 d
C. racemosa Methanol 2.51 ± 0.09 c,g
Water 7.46 ± 0.20 b,f
Chloroform 2.20 ± 0.10 c,g
C. lentillifera Methanol 9.74 ± 0.59 b,f
Water 81.55 ± 4.22 e
Data are expressed as mean ± SE of three separate independent experiments. Means with different alphabet are
significantly different at p < 0.05 (Games–Howell).
Overall, the results of TPC of both species are in agreement with the antioxidant activity,
in descending order from chloroform > methanol > water. This suggests that the antioxidant activity
of the extracts may be contributed mainly by the phenolics in the extracts. The difference in trend in
the TFC of C. racemosa and C. lentillifera extracts compared to the antioxidant activity and TPC indicates
that the antioxidant activity in the chloroform extract may be attributed to the phenolic compounds
but not to the flavonoid compounds.
2.4. Antibacterial Assay
2.4.1. Screening of Antibacterial Effect at 250 µg/mL
Antibacterial property of the seaweed extracts was determined by performing antibacterial assay
and calculating the percentage of antibacterial effect of each extract on MRSA and E. coli K1. Table 4
shows the percentages of antibacterial effect of each crude extract against two microorganisms.
The chloroform extract of C. racemosa shows the highest percentage of antibacterial effect
(97.7 ± 0.30%) against MRSA compared to all other crude extracts from this seaweed species, but this
extract does not show similar promising results against E. coli K1. The water extract from C. racemosa
encourages the growth of both MRSA and E. coli K1 by −237.79 ± 18.62% and −37.00 ± 2.86%,
respectively. On the other hand, chloroform extract of C. lentillifera gives a moderate antibacterial effect
of 62.17 ± 6.60% on MRSA but poorly on E. coli K1 (12.42 ± 3.83%). The water extract of C. lentillifera
encourages the growth of both microorganisms, showing a similar trend as observed in the water
extract of C. racemosa. Also, in both species of seaweeds, the methanol extracts only show a moderate
antibacterial effect against both MRSA and E. coli K1. Therefore, based on the trend of the antibacterial
effect of the crude extracts, (1) the chloroform extract of C. racemosa has the most promising antibacterial
effect, and (2) the antibacterial compound(s) are very effective against Gram-positive bacteria than that
on Gram-negative bacteria.
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Table 4. Percentage of antibacterial effect of seaweed crude extracts against MRSA and E. coli K1.
Seaweed Extracts and Controls
Antibacterial Effect (%)
MRSA E. coli K1
C. racemosa Extract
Chloroform 97.70 ± 0.30 * 19.90 ± 4.05
Methanol 61.54 ± 2.19 *** 42.91 ± 7.75
Water −237.79 ± 18.62 *** −37.00 ± 2.86 **
C. lentillifera Extract
Chloroform 62.17 ± 6.60 * 12.42 ± 3.83
Methanol 44.99 ± 2.42 ** 42.26 ± 12.67 *
Water −34.58 ± 2.71 −43.05 ± 0.99 ***
Controls
Pen-strep (10 U) 98.10 ± 0.10 100.00 ± 0.0
DMSO (0.5%) 15.90 ± 1.70 10.90 ± 3.70
Methanol (0.5%) 8.70 ± 1.56 11.80 ± 3.00
Water (0.5%) −28.30 ± 5.68 −9.72 ± 0.92
Percentage of antibacterial effect of seaweed crude extracts against MRSA and E. coli K1. 1 × 106 bacterial cells
(10 µL) were incubated with extract at 250 µg/mL (1 µL) in 189 µL of phosphate-buffered saline (PBS) for 2 h at
37 ◦C. Next, the samples were serially diluted (10-fold) and plated on Nutrient Agar followed by 18 h of incubation
at 37 ◦C. Finally, bacterial colonies were enumerated and recorded to obtain the percentage of reduction of bacterial
cells. The values represent mean ± SE of triplicate in three separate independent experiments. p-values of * p < 0.05,
** p < 0.01, and *** p < 0.001 were calculated using student’s t-test by comparing with the respective solvent control.
Abbreviations: DMSO, dimethyl sulfoxide; Pen-strep, penicillin-streptomycin.
2.4.2. Dose-Dependent Antibacterial Effect of C. racemosa Chloroform Extract
A dose-dependent antibacterial study of the chloroform extract of C. racemosa was performed as
it showed promising antibacterial effect against MRSA. Here, we found that the antibacterial effect
of C. racemosa chloroform extract acts in a dose-dependent manner. The highest antibacterial effect
is observed at 250 µg/mL, and even at a concentration of 25 µg/mL, the extract demonstrates potent
antibacterial effect against MRSA (54.1 ± 0.7%) (Figure 1).
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Figure 1. Dose-dependent antibacterial effect of C. racemosa chloroform extracts on MRSA. 1 × 106 
bacterial cells were incubated with extract at 5 μg/mL, 10 μg/mL, 25 μg/mL, 50 μg/mL, 100 μg/mL, 
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1. Dose-d pendent antibacterial effect of C. racemosa chloroform extracts on MRSA.
1 × 106 bacterial cells were incuba ed with extract at 5µg/mL, 10µg/mL, 25µg/mL, 50µg/mL, 1 0µg/ L,
250 µg/mL for 2 h at 37 ◦C. Next, the samples were serially d luted (10-fold) and plated on Nutrient
Aga followed by 18 h of incubati n at 37 ◦C. Finally, bacterial colonies were enumerat d and record
to obtain the % of reduction of bacterial cells. Results represent three independent experiments
performed in triplicates. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.
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2.4.3. Heat Treatment of C. racemosa Chloroform Extract
In order to partially characterize the nature of the compound(s) that are responsible for the
promising antibacterial effect against MRSA, we heated the C. racemosa chloroform extract at 95 ◦C for
30 min prior to use to find out if the antibacterial compound(s) are proteinaceous in nature. Based on
our results, heat treatment does not alter the antibacterial effect of the chloroform extract. As shown on
Figure 2, heat-treated extract exhibits 97.7 ± 0.4% of antibacterial effect, while the non-heated extract
shows 97.0 ± 0.2% of antibacterial effect. The evidence indicates that the compound(s) responsible for
the antibacterial effect is not proteinaceous in nature, and most likely to be small molecules.
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Figure 2. Heat treatment of C. racemosa chloroform extract. C. racemosa chlorof m extract at 250 µg/mL
was heated at 95 ◦C for 30 min prior to use for antibacterial studies. 1 × 106 bacterial cells were then
incubated with the heated and non-heated C. racemosa chloroform extract, respectively, for 2 h at
37 ◦C. Next, the samples were serially diluted (10-fold) and plated on Nutrient Agar followed by 18 h
of incubation at 37 ◦C. Finally, bacterial colonies were enumerated and recorded to obtain the % of
reduction of bacterial cells. Results represent three independent experiments performed in triplicates.
* indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.
2.5. Liquid Chromatography–Mas Spectro etr lysis
Using LCMS and the set parameters, our LCMS results detected 74 peaks in the positive ion mass
spectra, while 48 peaks were present in the negative ion mass spectra, making a total of 122 peaks,
hence 122 small molecules in the C. racemosa chloroform extract. Twenty-three of these compounds
matched with identity of known molecules on the Metlin database, with Molecular Formula Generator
(MFG) scores above 90% and a ±2 difference in MFG scores. The proposed compounds were researched
and are presented in Supplementary Materials Table S1. Many of these molecules are polyunsaturated
and monounsaturated fatty acids, terpenes, and alkaloids. Interestingly, 25 other compounds that had
MFG scores above the cut-off had no matched identity in the library, indicating a large family of new
compounds that are yet to be explored in this seaweed extract (Supplementary Materials Table S2).
The chromatograms and MS spectra of compounds can also be found in the Supplementary Materials
Figures S1–S3.
3. Discussion
Seaweeds are a unique source of natural marine products due to their ability to thrive in the
dynamic environment of the ocean. In the current work, we explored the antioxidant and antibacterial
potentials in both C. racemosa and C. lentillifera, which are edible seaweeds widely found in the Southeast
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Asian countries. Although both are different species, the names ‘sea grapes’ or ‘sea caviar’ are used
interchangeably by locals to describe them, and they are usually eaten raw as salad. The consumption
of these sea grapes is associated with palatable taste and nutritional properties, although the latter has
not been explored thoroughly [46].
The consumption of antioxidants has become an indispensable group of food products/additives
due to their proven health benefits [47,48]. The antioxidant property of natural products is usually
attributed by the presence of polyphenols, including phenolics and flavonoids. In this study,
phytochemical tests were carried out to determine the TPC and TFC contents in crude extracts
of C. racemosa and C. lentillifera. Of all the extracts, the chloroform extract of C. racemosa had the
highest TPC value and antioxidant activity, indicating that the antioxidant activity may be associated
with the phenolics in the extract. In contrast, the TFC values of C. racemosa had a distinct trend
compared to the TPC values, suggesting that the other phenolic compounds are responsible for
the antioxidant activity but not flavonoids. For instance, there are studies showing that a phenolic
compound known as phlorotannin, isolated from brown seaweeds, has high antioxidant activity,
which indicates that phenolic compounds do play a role in the antioxidant activity of seaweeds [49,50].
However, the identities of the phenolics responsible for the antioxidant activity from C. racemosa have
not been reported to date, but it is an area that can be explored in the future. The positive correlation
in the TPC and the antioxidant activity was also observed in the studies conducted on C. racemosa
by Chew et al. [51], Li et al. [52], and Chia et al. [41]. As compared to other studies, the TPC of the
chloroform extract of C. racemosa (13.41 ± 0.86 mg GAE/g) is higher than that of Gracilaria manilaensis
(0.45 ± 0.06 mg GAE/g) [53], but lower than that of a Korean green seaweed, Enteromorpha prolifera,
chloroform extract (80.40 ± 2.10 mg GAE/g) [54]. In comparison to several more green seaweeds from
the Persian Gulf, south of Iran, the TPC of the chloroform extract of C. racemosa in the current study is
also higher compared to the methanolic extract of Ulva clathrata (5.08 ± 0.65 mg GAE/g), Ulva linza
(1.99 ± 0.29 mg GAE/g), Ulva intestinalis (1.98 ± 0.30 mg GAE/g), and Ulva flexuosa (2.67 ± 0.22 mg
GAE/g) [27]. On the other hand, the DPPH radical scavenging activity obtained from the chloroform
extract of C. racemosa in our study is higher (EC50 at 0.65 mg/mL) than that of a Malaysian red seaweed,
Acanthophora spicifera (EC50 at 0.78 mg/mL) [55], but lower than that in another species of red seaweed,
Halopitys incurvus, from Morocco (EC50 at 0.15 mg/mL) [56]. Also, when compared to another two
green seaweeds, namely Ulva expansa and C. sertularioides, their methanol extracts showed weaker
antioxidant activity (EC50 at 133.1 mg/mL and EC50 at 116.4 mg/mL, respectively) [57] compared to the
chloroform extract of C. racemosa in this study. This shows that the phenolic content may vary from
location to location and between different species of seaweeds, but the potential of C. racemosa as an
antioxidant source is evident.
The second half of the present study explored the antibacterial property of C. racemosa and
C. lentillifera. This is in line with the World Health Organization’s ‘Global Action Plan on Antimicrobial
Resistance’ strategic objective which encourages researchers to develop new treatment options [58].
Our results suggest that these two seaweeds are potential novel sources of antibacterial compounds and
these compounds are most likely heat stable. As shown earlier, the chloroform extract of C. racemosa
has the most promising antibacterial effect against MRSA (Gram-positive bacteria) while methanol
extract of C. racemosa has moderate antibacterial effects against E. coli K1 (Gram-negative bacteria).
Our findings reveal that the crude seaweed extracts are more effective against Gram-positive bacteria
compared to that against Gram-negative bacteria. This may be due to the difference in their cell wall
structures, as well as composition [59,60]. This is similar to a study by Chan et al. [36], using the broth
microdilution method, where the Gram-positive bacteria (Bacillus cereus and Staphylococcus aureus) were
susceptible towards the chloroform extract of C. racemosa but the extract was not effective against E. coli.
In contrast, other studies by Kandhasamy and Arunachalam [42] and Nagaraj and Osborne [44] using
the disc diffusion method and the well diffusion method, respectively, reported that the methanolic
extract of C. racemosa from India had effective antibacterial effect against both Gram-positive and
Gram-negative bacteria. Also, in comparison with some Malaysian brown seaweeds from other
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studies using the disc diffusion method, Gram-positive bacteria (Bacillus subtilis and S. aureus) and
Gram-negative bacteria (Pseudomonas aeruginosa and E. coli) were not susceptible towards chloroform
extracts of Sargassum plagyophillum, Sargassum flavellum, Padina australis, and Sargassum binderi [34].
However, the Gram-positive bacteria were mostly susceptible towards the methanolic, acetone, and
ethyl acetate extracts of Sargassum plagyophillum, Sargassum flavellum, and Sargassum binderi [34].
Interestingly, a study conducted in Saudi Arabia using the disc diffusion method showed that the
chloroform extract of another member of the Caulerpa genus, Caulerpa occidentalis, was very effective
against E. coli but only moderately against S. aureus and Enterococcus faecalis [61]. The difference in our
results with other studies suggests that apart from the seaweed species tested, there are other factors
that may influence the synthesis of desired bioactive compounds such as geographical localization of
the seaweeds and method of extraction [42].
Our data suggest that the chloroform extract of C. racemosa is a potent antioxidant and antibacterial
agent, and the antibacterial effect might be attributed to a bioactive compound(s) that is non-heat
sensitive. LCMS data reveal a wide spectrum of chemical classes, including polyunsaturated and
monounsaturated fatty acids, terpenes, and alkaloids, that are potentially present in the extract
(Supplementary Materials Table S1). Out of the 23 proposed compounds (with MFG scores above 90%),
only Pristimerin (Compound 1) has been reported to have antioxidant activity [62], while Pheophorbide
a (Compound 12) has been reported with antioxidant and antibacterial effects [63,64], which could
be responsible for the observed potent antibacterial effect, as well as antioxidant activity. However,
there are 25 more compounds (Supplementary Materials Table S2) from the extract that have no
matched identity on the library, which may be novel compounds that are medically essential, but further
characterization is needed to determine their uses. According to Yang et al. [3], Guerriero et al. [65],
and Smyrniotopoulos et al. [66], Caulerpa genus seaweeds synthesize a plethora of metabolites from
the bisindole alkaloids and terpenoids classes (including sesquiterpenoids and diterpenoids), which
support our findings, where compounds such as Compound 2 (Caulerpin, a bisindole alkaloid),
Compound 4 (Isoamijiol, a diterpenoid), and Compound 23 (Methyl farnesoate, a sesquiterpenoid) are
identified from the chloroform extract of C. racemosa. In fact, Caulerpin was successfully isolated from
C. racemosa and C. lentillifera (harvested in Sabah, Malaysia) and identified as the compound responsible
for the potent antibacterial effect in green seaweeds [38]. Therefore, it is believed that Caulerpin might
play a role in the antibacterial effect in C. racemosa and C. lentillifera, but it is still not clear if this is the only
compound exhibiting the antibacterial effect. Interestingly, the compounds listed in Supplementary
Materials Table S1 are not phenolics but are mostly polyunsaturated fatty acids (PUFA) such as
Compound 6 (12(13)-epoxy-9Z,15Z-octadecadienoic acid), Compound 7 (9Z,12Z,15E-octadecatrienoic
acid), and Compound 9 (trans-5, trans-8, trans-11-hexadecatrienoic acid), to name a few. As far as we
are concerned, the bioactivity of these PUFAs has not been reported yet, but there are studies showing
that PUFAs have antioxidant property [67,68] and antibacterial property [69–72]. However, it is also
possible that there are phenolics in various amounts among the unidentified 25 compounds found
in the extract and may be collectively contributing to the antioxidant effect observed here. Overall,
only a little is known about the antioxidant and antibacterial properties of the compounds listed in
Supplementary Materials Table S1. Our preliminary LCMS analysis suggests that further investigation
is required. In the near future, tandem LCMS (LCMS/MS) can be used to reveal the small molecules
present in the chloroform extract of C. racemosa with a higher level of confidence.
Seaweeds are found under the sea, a challenging environment with constant exposure to various
microorganisms [73]. The search for novel antibacterial compounds in marine seaweeds has been of
interest to various research groups around the world. Studies on the antibacterial effect of red and
brown seaweeds have already attracted much attention from scientists, but such studies in green
seaweeds are still lacking [1]. For instance, eight novel potent antibacterial compounds against MRSA
identified as Chrysophaentins A–H, were successfully isolated from a golden seaweed, Chrysophaeum
taylori [74], while Bromophycolides P and Q with strong antibacterial effect against vancomycin-resistant
Enterococcus faecium (VREF) were isolated form a red seaweed, Callophycus serratus [75]. These findings
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have demonstrated that seaweeds are a potential source of novel antibacterial compounds and should
be investigated in the discovery of new therapeutic drugs against ARB.
The current study examined the susceptibility of two pathogenic bacteria, MRSA and E. coli K1,
representing Gram-positive and Gram-negative bacteria, respectively, towards the seaweed extracts.
MRSA is an ARB that can cause severe skin infections and if left untreated, may lead to sepsis. In 2005
alone, more than 18,000 deaths were reported in the U.S. [76] and the number of MRSA-associated
hospitalization cases doubled from 1998 to 2007 in the U.S., suggesting that the infection has become
more prevalent over the years [77]. Compounding the issue, MRSA has been reported to acquire
resistance against newer antibiotics intended for MRSA such as daptomycin-, vancomycin-, and
teicoplanin [78–80]. The selected Gram-negative bacterium, E. coli K1, is a prevalent causative
agent for neonatal meningitis. The emergence of extended-spectrum beta lactamase (ESBL) [81] and
carbapenem-resistant E. coli strains [82] are on the rise, further reducing the therapeutic options
for patients. The findings of the present study undoubtedly shed light on the development of new
antibacterial agents against these deadly pathogens.
The extracts from each of the seaweeds exerted different strengths of antioxidant and antibacterial
effects, possibly due to the difference in the bioactive compounds present in each extract, growth stage
of the seaweeds, and seasonal variations [1]. By referring to the yield percentages of the extracts,
the water extract of C. lentillifera has the highest yield. This demonstrates that C. lentillifera possesses a
high content of more polar compounds, which are effectively extracted by water. While a variety of
solvents have been used to prepare seaweed extracts for antioxidant and antibacterial testing, there
are still no optimal solvents to prepare an extract with the most effective antioxidant or antibacterial
activity in seaweeds, because numerous factors such as the species of seaweed used and the species of
bacteria we are targeting need to be taken into consideration [1]. For instance, Cox et al. [83] suggest
that methanol is a better solvent to prepare extract with promising antibacterial property in brown
seaweed, while acetone is effective for red and green seaweeds. In contrast, Moubayed et al. [84]
recommend methanol to extract effective antibacterial compounds from brown and green seaweeds.
As for the extraction of effective antioxidant compounds, Airanthi et al. [85] found that methanol is the
most effective solvent in extracting antioxidant compounds from brown seaweeds, while Chakraborty
and Raola [86] found that using ethyl acetate for the extraction of antioxidant compounds from
red seaweeds is more effective compared to dichloromethane and hexane. Nevertheless, a suitable
solvent for the most effective extraction of antioxidant and antibacterial compounds is still vague,
and further studies in this area are needed to increase our understanding on the choice of solvent for
effective extraction.
Intriguingly, the water extract of both seaweeds encouraged the growth of both the bacteria tested,
showing a possibility that water extracts contain nutrients that can support the growth of the bacteria.
For example, according to Egan et al. [87], the cell wall or other carbon-rich polymers (e.g., cellulose
and alginate) in seaweed may serve as a source of nutrients for bacteria that are capable of utilizing
them, thus supporting our hypothesis. These nutrients may be polar in nature and can be extracted by
water. Similar to another study by Kantachumpoo and Chirapart [4], the water extracts from seven
species of brown seaweed were not only inactive against all of the Gram-positive and Gram-negative
bacteria tested, but instead promoted their growth. This trend suggests that although seaweeds have
potent antibacterial property, they also have compounds that are able to support the growth of bacteria
regardless of their species. In recent years, the prebiotic potential of seaweeds has been explored [2].
The water extracts of C. racemosa and C. lentillifera may be evaluated for their prebiotic potentials due
to their potential to promote the growth of bacteria tested here.
Several environmental factors such as the temperature and salinity of the seawater fluctuate from
time to time which, in turn, affects the biology of the seaweeds. Ding et al. [88] reported that an increase
in water temperature from 15 ◦C to 25 ◦C led to an increase in the growth rates of a red seaweed known
as Hypnea cervicornis. However, the increased in temperature to 30 ◦C resulted in wilted seaweed.
In the case of salinity, the increase of NaCl concentration from 25% to 45% significantly increased
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the synthesis of a light-harvesting pigment known as Car pigment at 20 ◦C. Therefore, we cannot
exclude the possibility that the antioxidant and antibacterial effects in the seaweeds will not fluctuate
with the change in certain environmental factors. Further investigation focusing on the antioxidant
and antibacterial effects throughout the year can be explored to determine the fluctuations in those
properties. Besides, the promising antibacterial effects of C. racemosa is encouraging to us to proceed
by exploring the cytotoxicity of the extract, because it is crucial for a compound to be non-cytotoxic
and have promising desired effects at the same time. Although we observed promising antibacterial
effect from the extract, the mechanism of action of the antibacterial effect is still not known. Therefore,
future works should focus on isolating and purifying the compound(s) responsible for the desired
effects, as well as the mechanism of action. In addition, our study only utilized one Gram-positive and
one Gram-negative bacteria to represent the two groups of bacteria in their susceptibility towards the
seaweed extracts. This may underrepresent the results and the potential of the seaweeds as a source of
potent antibacterial compound(s). In order to determine the antibacterial effects of the extracts at a
broader spectrum, more species of bacteria should be included in the antibacterial studies.
In addition, future works should also explore the possibility of bacteria associated with C. racemosa
and C. lentillifera to investigate if they are responsible for the synthesis of antibacterial compounds.
This is because there are studies that have reported that seaweed-associated bacteria play crucial roles in
the development and growth of seaweeds, showing a symbiotic relationship between the bacteria and
the seaweeds [89]. Another study found a potential broad-spectrum antibacterial effect from epiphytic
bacteria (Phylum: Firmicutes; closely related to Bacillus pumilus) isolated from brown seaweed Padina
pavonica, thus suggesting that bacteria associated with seaweeds might be producers of antibacterial
compounds [90]. Recently, a study by Sujuliyani et al. [91] showed that C. racemosa has symbiotic bacteria
belonging to the genus Neisseria that is able to synthesize potential antibacterial compounds against
S. aureus and Salmonella typhi. Therefore, it is possible that symbiotic bacteria of seaweeds produce
compounds with antibacterial effect, protecting the seaweeds from other harmful microorganisms.
4. Materials and Methods
4.1. Seaweed Preparation
Fresh specimens of C. racemosa and C. lentillifera were collected from Port Dickson coastal area
(GPS Coordinate: N 2.413029; E 101.855892) in July 2017. The specimens were washed with sea salt
water and gently brushed to remove foreign objects and epiphytes. The seaweeds were then rinsed with
distilled water to remove excessive salts before storing at −20 ◦C. Next, seaweeds were freeze-dried
(Labogene SCANVAC Coolsafe Touch 110-4, Denmark) and then ground into fine powder with a food
grinder and kept at –20 ◦C prior to use.
4.2. Crude Extract Preparations
Seaweed extraction was performed via simple extraction with three solvents: Chloroform,
methanol, and water. Briefly, 1 g of seaweed powder of each species was incubated with the
appropriate solvent at room temperature for 2 h. The filtrates obtained were subjected to rotary
evaporation (Fisher Scientific EYELA N-1200A Rotary Evaporator, Tokyo) and further concentrated
using vacuum concentrator (SpeedScan 40, Korea) at 200 rpm. Finally, the dried extracts were stored at
−20 ◦C. Crude extracts were prepared in three separate independent extractions. The yield percentage
was calculated based on the dried mass of the extract and the initial weight of the powder used
for extraction.
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4.3. Phytochemical Screening
4.3.1. Determination of Total Phenolic Content (TPC)
The total phenolic content (TPC) of chloroform, methanol, and water extracts of C. racemosa and
C. lentillifera was measured by using the Folin–Ciocalteu method, as described by Singleton et al. [92],
with slight modifications. Briefly, 5 µL of 10 mg/mL from of each extract and gallic acid (as standard)
was mixed with 25 µL of FC reagent. Next, 395 µL of distilled water was added followed by 75 µL of
20% Na2CO3. The contents in the samples and standards were mixed thoroughly and allowed to stand
in dark for 60 min. Absorbance was read at 750 nm by using a spectrophotometer microplate reader
(Infinite 200 Pro, Tecan, Switzerland). The TPC values were calculated by the graphical method and
are expressed as milligram gallic acid equivalent per gram (mg GAE/g). All tests and controls were
tested in triplicates in three separate independent experiments.
4.3.2. Determination of Total Flavonoid Content (TFC)
The total flavonoid content (TFC) of chloroform, methanol, and water extracts of C. racemosa and
C. lentillifera was measured according to the method described by Pękal and Pyrzynska [93], with slight
modifications. Briefly, 10 µL of 10 mg/mL from of each extract and Quercetin (as standard) (Sigma Life
Sciences, Germany) was mixed with 250 µL of 2% aluminum chloride (Sigma-Aldrich, Germany). Next,
250 µL of 1 M acetic acid was added followed by 490 µl of distilled water. The contents in the samples
and standards were mixed thoroughly and allowed to stand in dark for 15 min. Absorbance was
read at 425 nm by using a spectrophotometer microplate reader (Infinite 200 Pro, Tecan, Switzerland).
The TFC values were calculated by the graphical method and are expressed as milligram quercetin
equivalent per gram (mg QE/g). All tests and controls were tested in triplicates in three separate
independent experiments.
4.4. Determination of DPPH Radical Scavenging Activity
The antioxidant activity of extracts was determined using the 2,2-diphenyl-1-picrylhydrazyl
(DPPH) scavenging activity as described by Pang et al. [94], with slight modifications. A positive
control was prepared using Ascorbic acid (Sigma, Germany). Briefly, 50 µL of the seaweed samples and
the positive control was mixed with 1 mL of 0.1 mM DPPH (Alfa Aesar, U.S), followed by incubation in
the dark for 30 min. The absorbance was then measured using spectrophotometer (Tecan, Switzerland)
at 518 nm. All tests and controls were tested in three separate independent experiments. The DPPH
radical scavenging activity percentage was calculated with Equation (1) stated below:
DPPH radical scavenging activity (%) =
(
1−
Absorbance of samples at 518nm
Absorbance of negative control at 518nm
)
× 100% (1)
The antioxidant results are expressed as half-maximum effective concentration (EC50), calculated
by utilizing the dose-dependent curve of percentage of DPPH radical scavenging activity versus the
concentrations of the respective samples/standards.
4.5. Antibacterial Assay
4.5.1. Screening of Antibacterial Effect at 250 µg/mL
Antibacterial assays were carried out as previously described by Lee et al. [95] and Khan et al. [96]
with slight modifications to determine the antibacterial effect of the seaweed extracts. Gram-positive
bacteria Methicillin-resistant Staphylococcus aureus (MRSA) (MTCC 381123) and Gram-negative bacteria
Escherichia coli K1 (MTCC 710859) were used in this study. The test bacteria were grown in Nutrient
Broth for 18 h at 37 ◦C prior to use. Approximately 1× 106 CFU (10 µL) of cells were incubated with 1 µL
of seaweed extract at a final concentration of 250 µg/mL in 189 µL of PBS followed by incubation for 2 h
Antibiotics 2019, 8, 152 12 of 18
at 37 ◦C. The extracts were diluted in their respective solvent, except for chloroform extract, which was
dissolved in dimethyl sulfoxide (DMSO). The incubated cultures were then serially diluted (10-fold) in
sterile distilled water and plated on nutrient agar plates. The plates were incubated overnight at 37 ◦C
and the bacterial colonies were then manually enumerated and recorded. Penicillin-streptomycin
(10 U) was used as the positive control, whereas solvent controls were prepared by incubating the
bacterial cultures in 0.5% of the appropriate extract solvent (methanol, water, or DMSO). All tests and
controls were tested in triplicates in three separate independent experiments. The formula used to
calculate the CFU/mL of the bacteria is stated as Equation (2) while the percentage of antibacterial
effect based on the CFU/mL was calculated using the Equation (3) stated below:
CFU/mL =
No. of colonies×Dilution factor
0.01 mL
(2)
Percentage of antibacterial effects (%) =
CFU
mL of Nontreated sample −
CFU
mL of Treated sample
CFU
mL of Nontreated sample
× 100% (3)
4.5.2. Dose-Dependent Antibacterial Effect of C. racemosa Chloroform Extract
The antibacterial assays were conducted as mentioned earlier but with different concentrations
of chloroform extracts of C. racemosa to investigate if the antibacterial effect exhibited by chloroform
extract of C. racemosa acts in a dose-dependent manner. The final concentrations of the extract tested
were 5, 10, 25, 50, 100, and 250 µg/mL. All tests and controls were tested in triplicates in three separate
independent experiments.
4.5.3. Heat Treatment of C. racemosa Chloroform Extract
Heat treatment on the chloroform extract of C. racemosa was conducted to determine if the
bioactive compound(s) responsible for the antibacterial effect is proteinaceous in nature. Briefly,
the antibacterial assay was performed as elucidated earlier but the extract was heated at 95 ◦C for
30 min prior to use for antibacterial studies. All tests and controls were tested in triplicates in three
separate independent experiments.
4.6. Liquid Chromatography–Mass Spectrometry (LCMS) Analysis
4.6.1. Liquid Chromatography–Mass Spectrometry (LCMS): Separation and Analysis
The C. racemosa chloroform extract was analyzed using a LCMS on Agilent 1290 infinity
liquid chromatograph (Agilent Technologies, Wilminton, DE, USA), coupled with an Agilent 6520
Accurate-Mass Q-ToF Mass Spectrometer with dual ESI source. Separation of compound was achieved
using reverse-phase HPLC with an Agilent Zorbax Eclipse XDB-C18 column, Narrow-Bore 2.1 ×
150 mm, of particle size 3.5 µm at 25 ◦C, and equilibrated with solvent A (0.1% formic acid in Milli-Q
water) and solvent B (0.1% formic acid in acetonitrile). The flow rate was set at 0.5 mL per min.
The total run time was 30 min, including a 25 min run time, and a 5 min post-run time. The ESI-TOF/MS
conditions were optimized as follows: Drying gas temperature, 300 ◦C; drying gas flow, 10 L/min;
nebulizer gas pressure, 45 psi; capillary voltage, 3500 V for positive ion mass spectra and 4000 V for
negative ion mass spectra; fragmentation voltage, 125 V; and skimmer, 65 V. The mass spectrum was
scanned from m/z 100 to m/z 3200 in both the positive and negative ionization modes. Calibration
reference solutions obtained from Agilent were used to calibrate the mass spectrometer daily. Reference
solution was used and the two ions with m/z of 119.03632 and 966.0097 were selected for mass
calibration in order to eliminate systematic errors.
4.6.2. Identification of Compounds Through Matching with Library
Chloroform extract of C. racemosa was subjected to LCMS to obtain the chromatograms and
the prospective mass spectra of every separated fraction of the mixture of compounds. The MS
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spectra for the compounds present in the extract were run against the NIST Mass Spectral Search
Program-2009 version 2.0f (National Institutes of Standard and Technology, Gaithersburg, MD, USA)
for the identification of homologous compounds through Agilent MassHunter Qualitative Analysis
B.05.00 software.
4.7. Statistical Analysis
All data collected were in triplicates of three independent experiments, except yield percentage,
DPPH radical scavenging activity, and LCMS analysis. The results are presented as mean ± standard
error (SE). The statistical analysis of antibacterial studies was carried out using student’s t-test
(two-tailed). The results of the yield percentage, phytochemical assays, and DPPH radical scavenging
activity were subjected to one-way analysis of variance (ANOVA) with post-hoc tests (Tukey for
yield percentage and TPC; Games–Howell for TFC and DPPH radical scavenging activity) using
SPSS Statistics Version 23 for the analysis of significant differences (p < 0.05) in the properties tested
between extracts.
5. Conclusions
In conclusion, C. racemosa is shown to have promising antioxidant potential and antibacterial effect
against Gram-positive bacteria. Our findings also reveal that heat-treatment on the chloroform extract
of C. racemosa does not alter the antibacterial effect, suggesting that the antibacterial compound(s) in
the extract is not proteinaceous in nature but could be non-thermolabile small metabolites. Besides,
we also observed a positive correlation between the TPC, antioxidant, and antibacterial activities from
C. racemosa suggesting that these two properties may be contributed by phenolics but not flavonoids,
due to the difference in trend in the TFC results. Nevertheless, C. racemosa may be a novel source for
antioxidant and antibacterial compounds and has high potential to be harnessed for the development
of pharmaceutically useful drugs. Further and more in-depth studies are required to build our
understanding on the mechanism of action, identity of the specific compound(s) responsible for the
desired effects, and also to expand our knowledge on the other hidden potentials in C. racemosa.
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